FDA Media Alert Detail

Drug Recall

FDA Drug Recall: Levothyroxine Sodium Tablets, USP, 125 mcg (0.125 mg), 1000-count bottles, Rx Only, Manufactured for...

  • U.S. Food and Drug Administration
  • September 2, 2026
  • ID: D-0781-2026

Drug Enforcement Report Details

Recall NumberD-0781-2026
Recalling FirmACCORD HEALTHCARE, INC.
ClassificationClass II
Voluntary / MandatedVoluntary: Firm initiated
Distribution PatternNationwide within the United States
StatusOngoing
Product Description

Levothyroxine Sodium Tablets, USP, 125 mcg (0.125 mg), 1000-count bottles, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-453-17.

Reason for Recall

Subpotent Drug

Code Information

Lot #: D2401983, Exp. Date 08/31/2026; D2402640, D2402641, Exp. Date 11/30/2026; D2500224, Exp. Date 01/31/2027.


Content syndicated from the U.S. Food and Drug Administration (FDA) drug enforcement reports database.